1. Home
  2. PRAX vs INFN Comparison

PRAX vs INFN Comparison

Compare PRAX & INFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRAX
  • INFN
  • Stock Information
  • Founded
  • PRAX 2015
  • INFN 2000
  • Country
  • PRAX United States
  • INFN United States
  • Employees
  • PRAX N/A
  • INFN N/A
  • Industry
  • PRAX Biotechnology: Pharmaceutical Preparations
  • INFN Telecommunications Equipment
  • Sector
  • PRAX Health Care
  • INFN Utilities
  • Exchange
  • PRAX Nasdaq
  • INFN Nasdaq
  • Market Cap
  • PRAX 1.2B
  • INFN 1.4B
  • IPO Year
  • PRAX 2020
  • INFN 2007
  • Fundamental
  • Price
  • PRAX $74.92
  • INFN $6.72
  • Analyst Decision
  • PRAX Strong Buy
  • INFN Buy
  • Analyst Count
  • PRAX 9
  • INFN 9
  • Target Price
  • PRAX $144.11
  • INFN $6.76
  • AVG Volume (30 Days)
  • PRAX 295.5K
  • INFN 10.1M
  • Earning Date
  • PRAX 11-05-2024
  • INFN 11-06-2024
  • Dividend Yield
  • PRAX N/A
  • INFN N/A
  • EPS Growth
  • PRAX N/A
  • INFN N/A
  • EPS
  • PRAX N/A
  • INFN N/A
  • Revenue
  • PRAX $1,771,000.00
  • INFN $1,495,486,000.00
  • Revenue This Year
  • PRAX N/A
  • INFN N/A
  • Revenue Next Year
  • PRAX N/A
  • INFN $10.67
  • P/E Ratio
  • PRAX N/A
  • INFN N/A
  • Revenue Growth
  • PRAX 20.97
  • INFN N/A
  • 52 Week Low
  • PRAX $13.01
  • INFN $2.82
  • 52 Week High
  • PRAX $75.73
  • INFN $6.92
  • Technical
  • Relative Strength Index (RSI)
  • PRAX 71.35
  • INFN 58.57
  • Support Level
  • PRAX $60.73
  • INFN $6.59
  • Resistance Level
  • PRAX $65.87
  • INFN $6.88
  • Average True Range (ATR)
  • PRAX 3.85
  • INFN 0.09
  • MACD
  • PRAX 1.22
  • INFN -0.03
  • Stochastic Oscillator
  • PRAX 96.03
  • INFN 44.83

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.

About INFN Infinera Corporation

Infinera Corp is a global supplier of networking solutions comprised of networking equipment, software and services. Its portfolio of solutions includes optical transport platforms, converged packet-optical transport platforms, compact modular platforms, optical line systems, coherent optical subsystems, a suite of automation software offerings, and support and professional services. The company's customers include operators of fixed line and mobile networks, including telecommunications service providers, internet content providers, cable providers, wholesale carriers, research and education institutions, large enterprises, utilities and government entities.

Share on Social Networks: